New York S05352 mandates prescribers and pharmacists to notify patients of any substitution of one generic drug product for another, both orally and.
New York S05352 amends the education law to require prescribers and pharmacists to inform patients when a different generic drug product is substituted for the one previously received. This notification must be provided both orally and in writing. The bill aims to ensure patients are aware of any changes in their medication.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.